MENU
+Compare
IKNA
Stock ticker: NASDAQ
AS OF
Jun 5 closing price
Price
$1.30
Change
-$0.04 (-2.99%)
Capitalization
62.98M

IKNA Ikena Oncology Forecast, Technical & Fundamental Analysis

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network... Show more

IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IKNA with price predictions
Jun 05, 2025

Momentum Indicator for IKNA turns positive, indicating new upward trend

IKNA saw its Momentum Indicator move above the 0 level on May 29, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned positive. In of the 95 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for IKNA just turned positive on May 21, 2025. Looking at past instances where IKNA's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

IKNA moved above its 50-day moving average on May 30, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IKNA crossed bullishly above the 50-day moving average on June 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where IKNA advanced for three days, in of 186 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IKNA moved out of overbought territory on June 05, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 13 similar instances where the indicator moved out of overbought territory. In of the 13 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IKNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IKNA broke above its upper Bollinger Band on June 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.547) is normal, around the industry mean (16.332). P/E Ratio (0.000) is within average values for comparable stocks, (59.787). IKNA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.227). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (99.010) is also within normal values, averaging (263.647).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IKNA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IKNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IKNA is expected to report earnings to fall 16.65% to -14 cents per share on August 07

Ikena Oncology IKNA Stock Earnings Reports
Q2'25
Est.
$-0.14
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.08
The last earnings report on May 08 showed earnings per share of -17 cents, beating the estimate of -19 cents. With 30.10K shares outstanding, the current market capitalization sits at 62.98M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
645 Summer Street
Phone
+1 857 273-8343
Employees
43
Web
https://www.ikenaoncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MU106.293.04
+2.94%
Micron Technology
COLD16.830.23
+1.39%
Americold Realty Trust
BLZE5.80-0.02
-0.34%
Backblaze
BEAM17.00-0.15
-0.87%
Beam Therapeutics
GRRR19.16-1.36
-6.63%
Gorilla Technology Group

IKNA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IKNA has been closely correlated with ABCZF. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if IKNA jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKNA
1D Price
Change %
IKNA100%
-2.61%
ABCZF - IKNA
72%
Closely correlated
N/A
ATRA - IKNA
72%
Closely correlated
+1.80%
VNDA - IKNA
37%
Loosely correlated
-1.35%
TERN - IKNA
35%
Loosely correlated
+1.14%
FATE - IKNA
35%
Loosely correlated
-5.63%
More

Groups containing IKNA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKNA
1D Price
Change %
IKNA100%
-2.61%
IKNA
(3 stocks)
18%
Poorly correlated
-0.27%